Taking antiviral treatment for a year after developing shingles helps prevent vision loss from the virus and any recurrence of the disease, research suggests.
The eight-year Zoster Eye Disease Study included more than 500 adults who had had previously had shingles and who also had damage to the anterior eye segment, including the iris, cornea and lens. Ocular shingles, or ophthalmic zoster, affects around 10% of people with shingles.
Participants who took daily valacyclovir 1000mg tablets for a year had 26% lower risk of worsening eye disease at 18 months, and were 30% less likely to have herpes zoster ophthalmicus flare-ups at 12 and 18 months compared with those who took the placebo.
A seven to 10-day course of valacyclovir is the recommended treatment for herpes zoster.
Results of the double-masked, placebo-controlled, multicentre randomised clinical trial were presented at the Cornea and Eye Banking Forum and the American Academy of Ophthalmology’s annual meeting in Chicago last month, and have not yet been published.